Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells

Immunology and Cell Biology

Volumn 88, Issue 2, 2010, Pages 148-156

  Jeon, Sung Tak ^a   Kim, Won Jung ^a   Lee, Sang Min ^a   Lee, Min Young ^a   Park, Seung Beom ^a   Lee, Seung Hee ^a   Kim, In San ^b   Suk, Kyoungho ^b   Choi, Beom Kyu ^c   Choi, Eun M ^c   Kwon, Byoung S ^c   Lee, Won Ha ^a  

^a Kyungpook National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c University of Ulsan   (South Korea)

Author keywords

Atherosclerosis; BAFF; Inflammation; Macrophage; Rheumatoid arthritis; Signaling transduction

Indexed keywords

B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAC1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL LINE; CELL MIGRATION; CELL MOTION; CELL STIMULATION; CONTROLLED STUDY; CYTOSKELETON; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; MEDIATOR; MONOCYTE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; THP 1 CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; CELL LINE; CELL MOVEMENT; CYTOSKELETON; ENZYME ACTIVATION; EXTRACELLULAR MATRIX PROTEINS; HUMANS; INFLAMMATION MEDIATORS; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; PHAGOCYTOSIS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; ZYMOSAN;

MURINAE;

EID: 77149145853     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.75     Document Type: Article

References (36)

1. Zhang J, Salcedo TW, Wan X, Ullrich S, Hu B, Gregorio T et al. Modulation of T-cell responses to alloantigens by TR6/DcR3. J Clin Invest 2001; 107: 1459-1468.
2. van Essen D, Kikutani H, Gray D. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 1995; 378: 620-623.
3. Chen NJ, Huang MW, Hsieh SL. Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine. J Immunol 2001; 166: 270-276.
4. Cerutti A, Schaffer A, Goodwin RG, Shah S, Zan H, Ely S et al. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells. J Immunol 2000; 165: 786-794.
5. Suzuki I, Fink PJ. The dual functions of fas ligand in the regulation of peripheral CD8+ and CD4+ T cells. Proc Natl Acad Sci USA 2000; 97: 1707-1712.
6. Chou AH, Tsai HF, Lin LL, Hsieh SL, Hsu PI, Hsu PN. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. J Immunol 2001; 167: 1347-1352.
7. Mackay F, Schneider P, Rennert P, Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 2003; 21: 231-264.
8. Gorelik L, Gilbride K, Dobles M, Kalled SL, Zandman D, Scott ML. Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J Exp Med 2003; 198: 937-945.
9. Ng LG, Mackay CR, Mackay F. The BAFF/APRIL system: life beyond B lymphocytes. Mol Immunol 2005; 42: 763-772.
10. Dillon SR, Gross JA, Ansell SM, Novak AJ. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov 2006; 5: 235-246.
11. Schneider P. The role of APRIL and BAFF in lymphocyte activation. Curr Opin Immunol 2005; 17: 282-289.
12. Kim HA, Jeon SH, Seo GY, Park JB, Kim PH. TGF-{beta}1 and IFN-{gamma} stimulate mouse macr. J Leukoc Biol 2008; 83: 1431-1439.
13. Chang SK, Arendt BK, Darce JR, Wu X, Jelinek DF. A role for BLyS in the activation of innate immune cells. Blood 2006; 108: 2687-2694.
14. Kim HJ, Kim IS. Transforming growth factor-beta-induced gene product, as a novel ligand of integrin alpha(M)beta(2), promotes monocytes adhesion, migration and chemotaxis. Int J Biochem Cell Biol 2008; 40: 991-1004.
15. Ballif BA, Shimamura A, Pae E, Blenis J. Disruption of 3-phosphoinositide-dependent kinase 1 (PDK1) signaling by the anti-tumorigenic and anti-proliferative agent n-alpha-tosyl-l-phenylalanyl chloromethyl ketone. J Biol Chem 2001; 276: 12466-12475.
16. Han Y, Englert JA, Yang R, Delude RL, Fink MP. Ethyl pyruvate inhibits nuclear factor-\{kappa\}B-dependent signaling by directly targeting p65. J Pharmacol Exp Ther 2005; 312: 1097-1105.
17. Wahl C, Liptay S, Adler G, Schmid RM. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest 1998; 101: 1163-1174.
18. Bae EM, Kim WJ, Suk K, Kang YM, Park JE, Kim WY et al. Reverse signaling initiated from GITRL induces NF-kappaB activation through ERK in the inflammatory activation of macrophages. Mol Immunol 2008; 45: 523-533.
19. Birdsall HH, Porter WJ, Green DM, Rubio J, Trial J, Rossen RD. Impact of fibronectin fragments on the transendothelial migration of HIV-infected leukocytes and the development of subendothelial foci of infectious leukocytes. J Immunol 2004; 173: 2746-2754.
20. Clark RA, Wikner NE, Doherty DE, Norris DA. Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment. J Biol Chem 1988; 263: 12115-12123.
21. May RC, Machesky LM. Phagocytosis and the actin cytoskeleton. J Cell Sci 2001; 114: 1061-1077.
22. Fenteany G, Glogauer M. Cytoskeletal remodeling in leukocyte function. Curr Opin Hematol 2004; 11: 15-24.
23. Bokoch GM. Regulation of innate immunity by Rho GTPases. Trends Cell Biol 2005; 15: 163-171.
24. Eissner G, Kirchner S, Lindner H, Kolch W, Janosch P, Grell M et al. Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages. J Immunol 2000; 164: 6193-6198.
25. Kang YJ, Kim SO, Shimada S, Otsuka M, Seit-Nebi A, Kwon BS et al. Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophages. Nat Immunol 2007; 8: 601-609.
26. Grohmann U, Volpi C, Fallarino F, Bozza S, Bianchi R, Vacca C et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 2007; 13: 579-586.
27. Lee MY, Kim WJ, Kang YJ, Jung YM, Kang YM, Suk K et al. Z39Ig is expressed on macrophages and may mediate inflammatory reactions in arthritis and atherosclerosis. J Leukoc Biol 2006; 80: 922-928.
28. Hu X, Moscinski LC, Valkov NI, Fisher AB, Hill BJ, Zuckerman KS. Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human myeloid leukemic cell line. Cell Growth Differ 2000; 11: 191-200.
29. Day ES, Cachero TG, Qian F, Sun Y, Wen D, Pelletier M et al. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry 2005; 44: 1919-1931.
30. Heidinger M, Kolb H, Krell HW, Jochum M, Ries C. Modulation of autocrine TNF-alphastimulated matrix metalloproteinase 9 (MMP-9) expression by mitogen-activated protein kinases in THP-1 monocytic cells. Biol Chem 2006; 387: 69-78.
31. Bae E, Kim WJ, Kang YM, Suk K, Koh EM, Cha HS et al. Glucocorticoid-induced tumour necrosis factor receptor-related protein-mediated macrophage stimulation may induce cellular adhesion and cytokine expression in rheumatoid arthritis. Clin Exp Immunol 2007; 148: 410-418.
32. Kim WJ, Bae EM, Kang YJ, Bae HU, Hong SH, Lee J et al. Glucocorticoid-induced TNFR family-related protein (GITR) mediates inflammatory activation of macrophages that can destabilize atherosclerotic plaques. Immunology 2006; 119: 421-429.
33. Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 2001; 50: 77-82.
34. Fragmentation of immunoglobulin G. In: Coligan JE, Bierer BE, Margulies DH, Shevach EM, Strober W (eds). Current Protocols in Immunology. Hoboken: John Wiley & Sons, Inc., 1998: 2.8.1-2.8.8.
35. Lee WH, Kim SH, Lee Y, Lee BB, Kwon B, Song H et al. Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler Thromb Vasc Biol 2001; 21: 2004-2010.
36. Kim WJ, Lee WH. LIGHT is expressed in foam cells and involved in destabilization of atherosclerotic plaques through induction of matrix metalloproteinase-9 and IL-8. Immune Network 2004; 4: 116-122.